Cerena™ AML is a digital therapeutic program to aid the physical health of people with Acute Myeloid Leukemia (AML). Cerena™ AML provides resources to help you manage your physical health conveniently located on your tablet, as a means to build resilience to stress and improve health outcomes.
The FDA recognizes that cancer patients are struggling now more than ever, and its recent enforcement guidance enables the program’s immediate release.